Literature DB >> 21636811

White matter hyperintensity penumbra.

Pauline Maillard1, Evan Fletcher, Danielle Harvey, Owen Carmichael, Bruce Reed, Dan Mungas, Charles DeCarli.   

Abstract

BACKGROUND AND
PURPOSE: White matter hyperintensities (WMHs) are associated with progressive age-related cognitive decline and cardiovascular risk factors, but their biological relevance as indicators of generalized white matter injury is unclear. Diffusion tensor imaging provides more sensitive indications of subtle white matter disruption and can therefore clarify whether WMHs represent foci of generalized white matter damage that extends over a broader neighborhood.
METHODS: Two hundred eight participants from the University of California, Davis Alzheimer's Disease Center received a comprehensive clinical evaluation and brain MRI including fluid-attenuated inversion recovery and diffusion tensor imaging sequences. Voxelwise maps of WMHs were produced from fluid-attenuated inversion recovery using a standardized WMH detection protocol. Fractional anisotropy maps were calculated from diffusion tensor imaging. All WMH and fractional anisotropy maps were coregistered to a standardized space. For each normal-appearing white matter voxel in each subject fluid-attenuated inversion recovery scan, a neighborhood white matter injury score was calculated that increased with increasing number and proximity of WMH in the vicinity of the normal-appearing white matter voxel. Fractional anisotropy was related to neighborhood white matter injury using a nonlinear mixed effect model controlling for relevant confounding factors.
RESULTS: Fractional anisotropy was found to decrease as neighborhood white matter injury increased (β = -0.0017/%, P < 0.0001) with an accelerated rate (P < 0.0001) for neighborhood white matter injury >0.4. An increase of 1% in neighborhood white matter injury score was associated with a decrease in mean fractional anisotropy of 0.012 (P < 0.001).
CONCLUSIONS: WMH may represent foci of more widespread and subtle white matter changes rather than distinct, sharply delineated anatomic abnormalities. We use the term white matter hyperintensities penumbra to explain this phenomenon.

Entities:  

Mesh:

Year:  2011        PMID: 21636811      PMCID: PMC3125449          DOI: 10.1161/STROKEAHA.110.609768

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease.

Authors:  Dong Young Lee; Evan Fletcher; Oliver Martinez; Natalia Zozulya; Jane Kim; Jeannie Tran; Michael Buonocore; Owen Carmichael; Charles DeCarli
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

2.  Different mechanisms of episodic memory failure in mild cognitive impairment.

Authors:  Christine Wu Nordahl; Charan Ranganath; Andrew P Yonelinas; Charles DeCarli; Bruce R Reed; William J Jagust
Journal:  Neuropsychologia       Date:  2005-02-05       Impact factor: 3.139

3.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

4.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; D Carmelli
Journal:  Arch Neurol       Date:  2001-04

5.  Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden.

Authors:  Charles DeCarli; Evan Fletcher; Vincent Ramey; Danielle Harvey; William J Jagust
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

6.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

Authors:  H C Chui; J I Victoroff; D Margolin; W Jagust; R Shankle; R Katzman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 7.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Periventricular venous collagenosis: association with leukoaraiosis.

Authors:  D M Moody; W R Brown; V R Challa; R L Anderson
Journal:  Radiology       Date:  1995-02       Impact factor: 11.105

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  88 in total

Review 1.  The back and forth of axonal injury and repair after stroke.

Authors:  Jason D Hinman
Journal:  Curr Opin Neurol       Date:  2014-12       Impact factor: 5.710

Review 2.  Structural Image Analysis of the Brain in Neuropsychology Using Magnetic Resonance Imaging (MRI) Techniques.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2015-08-18       Impact factor: 7.444

3.  Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia.

Authors:  K Miwa; S Okazaki; M Sakaguchi; H Mochizuki; K Kitagawa
Journal:  Eur J Neurol       Date:  2016-01-03       Impact factor: 6.089

4.  Cooccurrence of vascular risk factors and late-life white-matter integrity changes.

Authors:  Pauline Maillard; Owen T Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2015-01-14       Impact factor: 4.673

5.  Impact of white matter hyperintensities on surrounding white matter tracts.

Authors:  William Reginold; Kevin Sam; Julien Poublanc; Joe Fisher; Adrian Crawley; David J Mikulis
Journal:  Neuroradiology       Date:  2018-07-20       Impact factor: 2.804

6.  The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study.

Authors:  Mario Mascalchi; Andrea Ginestroni; Nicola Toschi; Anna Poggesi; Paolo Cecchi; Emilia Salvadori; Carlo Tessa; Mirco Cosottini; Nicola De Stefano; Giovanni Pracucci; Leonardo Pantoni; Domenico Inzitari; Stefano Diciotti
Journal:  Hum Brain Mapp       Date:  2012-12-08       Impact factor: 5.038

Review 7.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 8.  Disconnected aging: cerebral white matter integrity and age-related differences in cognition.

Authors:  I J Bennett; D J Madden
Journal:  Neuroscience       Date:  2013-11-23       Impact factor: 3.590

9.  Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Ho Kyun Kim; Won-Jin Moon
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

10.  Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.

Authors:  Mekala R Raman; Jayandra J Himali; Sarah C Conner; Charles DeCarli; Ramachandran S Vasan; Alexa S Beiser; Sudha Seshadri; Pauline Maillard; Claudia L Satizabal
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.